Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particlesShow others and affiliations
2008 (English)In: Biotechnology progress (Print), ISSN 8756-7938, E-ISSN 1520-6033, Vol. 24, no 5, p. 1122-1131Article in journal (Refereed) Published
Abstract [en]
Cell proliferation and long-term production of monoclonal antibody IgG(2b) by M2139 hybridoma cells immobilized in macroporous gel particles (MGPs) in packed-bed reactor were studied for a period of 60 days. The MGPs were made of supermacroporous gels produced in frozen conditions from crosslinked polyacrylamide and modified with gelatin which were housed in special plastic carriers (7 x 9 mm(2)). Cells were trapped in the interior part of MGPs by attaching to the void space of the gel matrix as three-dimensional (3D) cultivation using gelatin as a substrate layer. Optimizing productivity by hybridoma cell relies on understanding regulation of antibody production. In this study, the behavior of M2139 cells in two-dimensional cultures on multiwell plate surfaces was also investigated. The effect of three different medium such as basal medium Dulbecco's modified Eagle's medium (D-MEM) containing L-glutamine or L-glutamine + 2 mM alpha-ketoglutarate or L-alanyl-glutamine (GlutaMAXtrade mark) was studied prior to its use in 3D cultivation. The kinetics of cell growth in basal medium containing L-glutamine + alpha-ketoglutarate was similar to cells grown on GlutaMAX containing medium, whereas D-MEM containing L-glutamine showed lower productivity. With the maximal viable cell density (6.85 x 10(6) cells mL(-1)) and highest specific mAb production rate (3.9 mug mL(-1) 10(-4) viable cell day(-1)), D-MEM-GlutaMAX was further selected for 3D cultivation. Cells in MGPs were able to grow and secrete antibody for 30 days in packed-bed batch reactor, before a fresh medium reservoir was replaced. After being supplied with fresh medium, cells again showed continuous growth for another 30 days with mAb production efficiency of 50%. These results demonstrate that MGPs can be used efficiently as supporting carrier for long-term monoclonal antibody production. © 2008 American Institute of Chemical Engineers.
Place, publisher, year, edition, pages
Malden, MA: Wiley-Blackwell Publishing Inc., 2008. Vol. 24, no 5, p. 1122-1131
Keywords [en]
3D cultivation, Antibody production, Cell immobilization, M2139 hybridoma cells, Macroporous gel particles, Medium optimization
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:hh:diva-48845DOI: 10.1002/btpr.28ISI: 000260738900015PubMedID: 19194922Scopus ID: 2-s2.0-56249132172OAI: oai:DiVA.org:hh-48845DiVA, id: diva2:1719024
Note
Funding text: The work was financially supported by Protista Biotechnology AB (Lund, Sweden), Swedish Research Council/SIDA-research link project (A.K.), the Swedish Research Council (R.H.), the EU project LSHB-CT-2006-018661 (AUTOCURE), and LSHG-CT-2005-005203 (MUGEN), Department of Biotechnology, Govt. of India. S.N. and V.N. acknowledge the financial support from Swedish Research Council/SIDAresearch link project of A.K. for visiting fellowship to Lund, Sweden.
2022-12-142022-12-142023-02-17Bibliographically approved